Abstracts

ULTRADEEP ANALYSIS OF PRETHERAPY HIV PREDICTS GENETICALLY COMPLEX RESERVOIRS

Measuring the genetic characteristics of HIV populations is essential to understanding the formation of HIV reservoirs that persist during antiretroviral therapy (ART).  Analysis of plasma HIV using new next generation sequencing (NGS) approaches using primer ID [ultrasensitive single genome sequencing (uSGS)] and advanced bioinformatic analyses (Boltz et al 2016), yields large HIV sequence datasets with…

HIV CONTROLLERS HAVE LOW FREQUENCIES OF INTACT PROVIRAL DNA

Elite controllers or suppressors (ES) are subjects who control viral replication without antiretroviral therapy. Studies using standard DNA PCR assays or the quantitative viral outgrowth assay (QVOA) have shown that these subjects have smaller viral reservoirs than chronic progressors (CP) on antiretroviral therapy (ART). However, standard DNA PCR assays measure both defective and replication-competent virus…

CELL PROLIFERATION CONTRIBUTES TO THE INCREASE OF GENETICALLY INTACT HIV OVER TIME

Effective HIV eradication strategies require an understanding of the mechanisms maintaining persistent HIV during therapy. We examined the role of memory cell proliferation in maintaining genetically-intact proviruses over 4 years of effective therapy. Naïve (N), central (CM), transitional (TM) and effector (EM) memory CD4+ T-cells were sorted from the peripheral blood of two participants on long-term…

ART-TREATED SUBJECTS WITH LOW VIRAL RESERVOIR SHOW UNUSUAL HIV LATENCY DISTRIBUTION

Small-size viral reservoirs are predominantly found in HIV-1 controllers and individuals treated during acute/early HIV-1 infection. However, other HIV+ subjects could naturally also harbor low viral reservoirs. We have established a cohort of "Low Viral Reservoir Treated" subjects" (LoViReT) to further explore the mechanisms associated with low reservoir levels. 42 HIV+ subjects on ART and…